Literature DB >> 19320189

Progression of skin lesions from normal skin to squamous cell carcinoma.

Robert S Krouse1, David S Alberts, Anil R Prasad, Michael Yozwiak, Hubert G Bartels, Yun Liu, Peter H Bartels.   

Abstract

OBJECTIVE: To assess the changes in the nuclear chromatin pattern concomitant with progressive sun damage in skin biopsies ranging from sun-exposed, normal-appearing skin to squamous cell carcinoma (SCC). STUDY
DESIGN: Biopsies were taken from 140 cases with sun-exposed but histopathologically normal skin, from 20 cases visually assessed as pre-actinic keratosis (pre-AK) or early AK, from 30 cases of AK, and from 21 cases of SCC. A total of 21,094 nuclei were recorded from these biopsies. High-resolution digital imagery was recorded, and features descriptive of the nuclear chromatin pattern were computed. Both supervised learning and unsupervised learning algorithms were employed to derive progression plots.
RESULTS: With increased sun exposure, the proportion of nuclei exhibiting changes in the nuclear chromatin pattern rises notably. Using karyometry, no significant differences could be substantiated between nuclei collected from early AK sites and AK lesions. Cases of SCC fell into 2 distinct groups. A larger group (approximately 66.7% of cases) had characteristics similar to AK. A smaller group (approximately 33.3% of cases) represented much more progressed lesions.
CONCLUSION: Karyometric assessment can provide a numeric measure of progression for sun damage and of the deviation from normal in both AK and SCC lesions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19320189      PMCID: PMC4061044     

Source DB:  PubMed          Journal:  Anal Quant Cytol Histol        ISSN: 0884-6812            Impact factor:   0.302


  15 in total

1.  The role of treatment of actinic keratoses in the prevention of morbidity and mortality due to squamous cell carcinoma.

Authors:  R Marks
Journal:  Arch Dermatol       Date:  1991-07

2.  Metastatic cutaneous squamous cell carcinoma derived from actinic keratosis.

Authors:  S M Dinehart; P Nelson-Adesokan; C Cockerell; S Russell; R Brown
Journal:  Cancer       Date:  1997-03-01       Impact factor: 6.860

Review 3.  Solar keratoses.

Authors:  R Marks
Journal:  Br J Dermatol       Date:  1990-04       Impact factor: 9.302

4.  Nuclear morphometry in solar keratosis.

Authors:  P D Bozzo; L C Vaught; D S Alberts; D Thompson; P H Bartels
Journal:  Anal Quant Cytol Histol       Date:  1998-02       Impact factor: 0.302

Review 5.  Actinic keratoses. Differential diagnosis and treatment.

Authors:  J W Barnaby; A R Styles; C J Cockerell
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

6.  Malignant transformation of solar keratoses to squamous cell carcinoma.

Authors:  R Marks; G Rennie; T S Selwood
Journal:  Lancet       Date:  1988-04-09       Impact factor: 79.321

7.  Aneuploidy in actinic keratosis and Bowen's disease--increased risk for invasive squamous cell carcinoma?

Authors:  S Biesterfeld; K Pennings; E I Grussendorf-Conen; A Böcking
Journal:  Br J Dermatol       Date:  1995-10       Impact factor: 9.302

8.  Solar keratosis: an evolving squamous cell carcinoma. Benign or malignant?

Authors:  R M Hurwitz; L E Monger
Journal:  Dermatol Surg       Date:  1995-02       Impact factor: 3.398

9.  New concepts on the origin of squamous cell carcinomas of the skin: solar (senile) keratosis with squamous cell carcinoma--a clinicopathologic and histochemical study.

Authors:  B J Bendl; J H Graham
Journal:  Proc Natl Cancer Conf       Date:  1970

10.  Actinic damage in histopathologically normal skin.

Authors:  Peter H Bartels; Robert S Krouse; Anil R Prasad; Michael Yozwiak; Yun Liu; Hubert G Bartels; David S Alberts
Journal:  Anal Quant Cytol Histol       Date:  2008-12       Impact factor: 0.302

View more
  6 in total

1.  Nuclear morphometry identifies a distinct aggressive cellular phenotype in cutaneous squamous cell carcinoma.

Authors:  Evan S Glazer; Peter H Bartels; Anil R Prasad; Michael L Yozwiak; Hubert G Bartels; Janine G Einspahr; David S Alberts; Robert S Krouse
Journal:  Cancer Prev Res (Phila)       Date:  2011-06-02

2.  Phase IIB Randomized Study of Topical Difluoromethylornithine and Topical Diclofenac on Sun-Damaged Skin of the Forearm.

Authors:  Joanne M Jeter; Clara Curiel-Lewandrowski; Steven P Stratton; Paul B Myrdal; James A Warneke; Janine G Einspahr; Hubert G Bartels; Michael Yozwiak; Yira Bermudez; Chengcheng Hu; Peter Bartels; David S Alberts
Journal:  Cancer Prev Res (Phila)       Date:  2015-12-28

3.  Karyometry in atypical endometrial hyperplasia: a Gynecologic Oncology Group study.

Authors:  Peter H Bartels; Francisco A R Garcia; Cornelia L Trimble; James Kauderer; John Curtin; Peter C Lim; Lisa M Hess; Steven Silverberg; Richard J Zaino; Michael Yozwiak; Hubert G Bartels; David S Alberts
Journal:  Gynecol Oncol       Date:  2011-12-09       Impact factor: 5.482

Review 4.  Cancer Immunoprevention: Current Status and Future Directions.

Authors:  Mahsa Keshavarz-Fathi; Nima Rezaei
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-02-27       Impact factor: 4.291

5.  Chemopreventive efficacy of topical difluoromethylornithine and/or triamcinolone in the treatment of actinic keratoses analyzed by karyometry.

Authors:  Peter Bartels; Michael Yozwiak; Janine Einspahr; Kathylynn Saboda; Yun Liu; Christine Brooks; Hubert Bartels; David S Alberts
Journal:  Anal Quant Cytol Histol       Date:  2009-12       Impact factor: 0.302

6.  Evaluating IPMN and pancreatic carcinoma utilizing quantitative histopathology.

Authors:  Evan S Glazer; Hao Helen Zhang; Kimberly A Hill; Charmi Patel; Stephanie T Kha; Michael L Yozwiak; Hubert Bartels; Nellie N Nafissi; Joseph C Watkins; David S Alberts; Robert S Krouse
Journal:  Cancer Med       Date:  2016-09-26       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.